Salapuddin, Mudzremar K.

HRN: 27-03-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
CEFTRIAXONE 1G (VIAL)
04/26/2025
05/03/2025
IV
650mg
OD
T/C CNSI; PCAP
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamCentral Nervous SystemProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: